FindTrial
Sign In

Comparison Study on the Cerenkov Luminescence Imaging and Radioluminescence Imaging on Hyperthyoridism Patients

Comparison Study on the Cerenkov Luminescence Imaging and Radioluminescence Imaging on Hyperthyoridism Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-16008912
Enrollment
Unknown
Registered
2016-07-26
Start date
2016-07-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism/Tumor

Interventions

Gold Standard:
Index test:

Sponsors

Xijing Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: The hyperthyroidism patients who plan to receive 99mTcO4- thyroid scan or the patients with positive lymph nodes in 18F-FDG PET scan.

Exclusion criteria

Exclusion criteria: Claustrophobia; Severe hyperthyroidism patients with tremor; Patients who can not maintain static for 30s for imaging acquisition.

Design outcomes

Primary

MeasureTime frame
T/NT value;—

Countries

China

Contacts

Public ContactWang Jing

Xijing Hospital, Fourth Military Medical University

wangjing@fmmu.edu.cn+86 029-84771048

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026